effect of aprepitant on post-operation nausea vomiting of cholecystectomy surgery
Phase 3
Recruiting
- Conditions
- Condition 1: Nausea. Condition 2: vomiting.NauseaVomitingR11.0R11.1
- Registration Number
- IRCT20221110056459N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with ASA health scale of 1 or 2
patients who are candidated for cholecystectomy surgery
Exclusion Criteria
patients with ASA health scale of 3, 4 or 5
patients with other anesthesia methods
patients with any systemic diseases such as diabetes, asthma, cardiovascular diseases, gastroesophageal reflux, severe obesity, BMI > 30, hepatorenal diseases, neuromuscular diseases, psychiatric illnesses, alcoholic patients, drug abusers, smokers
pregnant or lactating patients
patients presented with acute cholecystitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of nausea. Timepoint: 6 and 24 hour post-operation. Method of measurement: VAS criteria.;Vomiting. Timepoint: 6 and 24 hour post-operation. Method of measurement: if vomiting happen or not.
- Secondary Outcome Measures
Name Time Method